IDEAYA signs 10-year lease for new 44,000 sq ft South San Francisco HQ

IDEAYA Biosciences, Inc.

Leased ~44,000 sq ft of lab/office space at 5000 Shoreline Ct, South San Francisco, adjacent to current HQ.
Total base rent over initial 10-year term net of abatement: $36.8 million.
Expected occupancy Q2/Q3 2024; two 5-year renewal options at market rate.
Company anticipates no material tenant improvement costs; facility supports R&D expansion.
Existing cash expected to fund operations into 2027, inclusive of lease expenses.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IDEAYA Biosciences, Inc. entered into Lease with DW LSP 5000 Shoreline, LLC valued at thirty-six million seven hundred sixty-five thousand seven hundred seventy-seven dollars in U.S. dol (effective 2023-06-01).

Action: entry
Agreement: lease
Counterparty: DW LSP 5000 Shoreline, LLC
Value: thirty-six million seven hundred sixty-five thousand seven hundred seventy-seven dollars in U.S. dol
Effective: 2023-06-01

Exact text from the filing

On June 1, 2023, IDEAYA Biosciences, Inc. (the “Company”) entered into a Lease (the “Lease”), dated June 1, 2023, with DW LSP 5000 Shoreline, LLC (“Landlord”).

View on SEC.gov

Browse all material agreements →

IDEAYA Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-026512

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.